12962_2020_205_MOESM5_ESM.docx (18.72 kB)
Additional file 5 of Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective
journal contribution
posted on 2020-02-11, 05:31 authored by Sarah Dewilde, Kevin Carroll, Emilia Nivelle, James SawyerAdditional file 5. Utilities by age and health state. Table showing details of the utility data, by age and health state, included in the model.